Медицинская литература. Новинки

 

 

 

 

 

 

Мультипараметрическая ультразвуковая диагностика рака предстательной железы

Вы можете загрузить полный текст статьи в формате pdf

В обзоре литературы рассматривается применение различных модальностей трансректального ультразвукового исследования в диагностике рака предстательной железы. Представлена диагностическая эффективность В-режима (включая микроультразвуковое исследование, использующее сверхвысокие частоты), различных методов оценки кровотока (включая микродопплеровское картирование), гистосканирования, эластографии (качественный и количественный анализ), контрастного усиления (качественный и количественный анализ). Показана роль магнитно-резонансного и ультразвукового совмещения (фьюжен) при биопсии предстательной железы. Обсуждаются перспективы объединения различных ультразвуковых методов в мультипараметрическое трансректальное ультразвуковое исследование, возможности создания стандартизированных шкал для описания выявленных изменений. Имеющиеся данные подтверждают, что использование современных технологий трансректального ультразвукового исследования значительно повышает его диагностическую точность, в том числе в выявлении клинически значимого рака предстательной железы.

Ключевые слова:
трансректальное ультразвуковое исследование (ТРУЗИ), допплеровское исследование, ультразвуковое исследование с контрастным усилением, ультразвуковая эластография, микродопплеровское картирование, микроультразвуковое исследование, мультипараметрическое ультразвуковое исследование, магнитно-резонансное и ультразвуковое совмещение (фьюжен), рак предстательной железы, transrectal ultrasound (TRUS), Do

Литература:
1.Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021; 71 (3): 209-249. https://doi.org/10.3322/caac.21660
2.Каприн А.Д., Старинский В.В., Шахзадова А.О. (ред.) Злокачественные новообразования в России в 2019 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена - филиал ФГБУ “НМИЦ радиологии” Минздрава России, 2020. 239 с.
3.Mottet N., van den Bergh R.C.N., Briers E., Van den Broeck T., Cumberbatch M.G., De Santis M., Fanti S., Fossati N., Gandaglia G., Gillessen S., Grivas N., Grummet J., Henry A.M., van der Kwast T.H., Lam T.B., Lardas M., Liew M., Mason M.D., Moris L., Oprea-Lager D.E., van der Poel H.G., Rouviere O., Schoots I.G., Tilki D., Wiegel T., Willemse P.M., Cornford P. EAU- EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur. Urol. 2021; 79 (2): 243-262. https://doi.org/10.1016Zj.eururo.2020.09.042
4.Willis S.R., van der Meulen J., Valerio M., Miners A., Ahmed H.U., Emberton M. A review of economic evaluations of diagnostic strategies using imaging in men at risk of prostate cancer. Curr. Opin. Urol. 2015; 25 (6): 483-489. https://doi.org/10.1097/mou.0000000000000220
5.Walz J. The “PROMIS” of magnetic resonance imaging cost-effectiveness in prostate cancer diagnosis? Eur. Urol. 2018; 73 (1): 31-32. https://doi.org/10.1016/j.eururo.2017.09.015
6.Rosenkrantz A.B., Verma S., Choyke P., Eberhardt S.C., Eggener S.E., Gaitonde K., Haider M.A., Margolis D.J., Marks L.S., Pinto P., Sonn G.A., Taneja S.S. Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR. J. Urol. 2016; 196 (6): 1613-1618. https://doi.org/10.1016/j.juro.2016.06.079
7.Watanabe H., Igari D., Tanahasi Y., Harada K., Saito M. Development and application of new equipment for transrectal ultrasonography. J. Clin. Ultrasound. 1974; 2 (2): 91-98. https://doi.org/10.1002/jcu.1870020203
8.McNeal J.E. The zonal anatomy of the prostate. Prostate. 1981; 2 (1): 35-49. https://doi.org/10.1002/pros.2990020105
9.Rifkin M.D., Dahnert W., Kurtz A.B. State of the art: endorectal sonography of the prostate gland. AJR Am. J. Roentgenol. 1990; 154 (4): 691-700. https://doi.org/10.2214/ajr.154.4.1690499
10.Sedelaar J.P., Vijverberg P.L., De Reijke T.M., de la Rosette J.J., Kil P.J., Braeckman J.G., Hendrikx A.J. Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives. Eur. Urol. 2001; 40 (3): 275-284. https://doi.org/10.1159/000049787
11.Ellis W.J., Chetner M.P., Preston S.D., Brawer M.K. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J. Urol. 1994; 152 (5 Pt 1): 1520-1525. https://doi.org/10.1016/s0022-5347(17)32460-6
12.Shinohara K., Wheeler T.M., Scardino P.T. The appearance of prostate cancer on transrectal ultra-sonography: correlation of imaging and pathological examinations. J. Urol. 1989; 142 (1): 76-82. https://doi.org/10.1016/s0022-5347(17)38666-4
13.Cornud F., Belin X., Piron D., Chretien Y., Flam T., Casanova J.M., Helenon O., Mejean A., Thiounn N., Moreau J.F. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology. 1997; 49 (5): 709-715. https://doi.org/10.1016/s0090-4295(96)00632-2
14.Halpern E.J., Strup S.E. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am. J. Roentgenol. 2000; 174 (3): 623627. https://doi.Org/10.2214/ajr.174.3.1740623
15.Song J.M., Kim C.B., Chung H.C., Kane R.L. Prostate-specific antigen, digital rectal examination and transrectal ultrasonography: a meta-analysis for this diagnostic triad of prostate cancer in symptomatic korean men. Yonsei Med. J. 2005; 46 (3): 414424. https://doi.Org/10.3349/ymj.2005.46.3.414
16.Hricak H., Choyke P.L., Eberhardt S.C., Leibel S.A., Scardino P.T. Imaging prostate cancer: a multidisciplinary perspective. Radiology. 2007; 243 (1): 28-53. https://doi.org/10.1148/radiol.2431030580
17.Ukimura O., Troncoso P., Ramirez E.I., Babaian R.J. Prostate cancer staging: correlation between ultrasound determined tumor contact length and pathologically confirmed extraprostatic extension. J. Urol. 1998; 159 (4): 1251-1259. https://doi.org/10.1016/s0022-5347(01)63575-4
18.Hardeman S.W., Causey J.Q., Hickey D.P., Soloway M.S. Transrectal ultrasound for staging prior to radical prostatectomy. Urology. 1989; 34 (4): 175-180. https://doi.org/10.1016/0090- 4295(89)90367-1
19.Rorvik J., Halvorsen O.J., Servoll E., Haukaas S. Transrectal ultrasonography to assess local extent of prostatic cancer before radical prostatectomy. Br. J. Urol. 1994; 73 (1): 65-69. https://doi.org/10.1111/j.1464-410x.1994.tb07458.x
20.Bates T.S., Gillatt D.A., Cavanagh P.M., Speakman M. A comparison of endorectal magnetic resonance imaging and transrectal ultrasonography in the local staging of prostate cancer with histopathological correlation. Br. J. Urol. 1997; 79 (6): 927-932. https://doi.org/10.1046/j.1464-410x.1997.00188.x
21.Colombo T., Schips L., Augustin H., Gruber H., Hebel P., Petritsch P.H., Hubmer G. Value of transrectal ultrasound in preoperative staging of prostate cancer. Minerva Urol. Nefrol. 1999; 51 (1): 1-4.
22.Ohori M., Shinohara K., Wheeler T.M., Aihara M., Wessels E.C., Carter S.S., Scardino P.T. Ultrasonic detection of non-palpable seminal vesicle invasion: a clinicopathological study. Br. J. Urol. 1993; 72 (5 Pt 2): 799-808. https://doi.org/10.1111/j.1464-410x.1993.tb16271.x
23.Russo G., Mischi M., Scheepens W., De la Rosette J.J., Wijkstra H. Angiogenesis in prostate cancer: onset, progression and imaging. BJU Int. 2012; 110 (11 Pt C): E794-E808. https://doi.org/10.1111/j.1464-410x.2012.11444.x
24.Miyata Y., Sakai H. Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurement. Int. J. Urol. 2015; 22 (9): 806-815. https://doi.org/10.1111/iju.12840
25.Erbersdobler A., Isbarn H., Dix K., Steiner I., Schlomm T., Mirlacher M., Sauter G., Haese A. Prognostic value of microvessel density in prostate cancer: a tissue microarray study. World J. Urol. 2010; 28 (6): 687-692. https://doi.org/10.1007/s00345-009-0471-4
26.Cheng S., Rifkin M.D. Color Doppler imaging of the prostate: important adjunct to endorectal ultra-sound of the prostate in the diagnosis of prostate cancer. Ultrasound Q. 2001; 17 (3): 185-189. https://doi.org/10.1097/00013644-200109000-00008
27.Taverna G., Morandi G., Seveso M., Giusti G., Benetti A., Colombo P., Minuti F., Grizzi F., Graziotti P. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling. BJU Int. 2011; 108 (11): 17231727. https ://doi.org/10.1111 /j. 1464-410x.2011. 10199.x
28.Kuligowska E., Barish M.A., Fenlon H.M., Blake M. Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers. Radiology. 2001; 220 (3): 757-764. https://doi.org/10.1148/radiol.2203001179
29.Rifkin M.D., Sudakoff G.S., Alexander A.A. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology. 1993; 186 (2): 509-513. https://doi.org/10.1148/radiology.186.2.7678467
30.Eisenberg M.L., Cowan J.E., Carroll P.R., Shinohara K. The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer. BJU Int. 2010; 105 (9): 1237-1241. https://doi.org/10.1111/j.1464-410x.2009.08958.x
31.Cho J.Y., Kim S.H., Lee S.E. Peripheral hypoechoic lesions of the prostate: evaluation with color and power Doppler ultrasound. Eur. Urol. 2000; 37 (4): 443-448. https://doi.org/10.1159/000020166
32.Sakarya M.E., Arslan H., Unal O., Atilla M.K., Aydin S. The role of power Doppler ultrasonography in the diagnosis of prostate cancer: a preliminary study. Br. J. Urol. 1998; 82 (3): 386-388. https://doi.org/10.1046/j.1464-410x.1998. 00753.x
33.Remzi M., Dobrovits M., Reissigl A., Ravery V., Waldert M., Wiunig C., Fong Y.K., Djavan B.; European Society for Oncological Urology (ESOU). Can Power Doppler enhanced transrectal ultra-sound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy? Eur. Urol. 2004; 46 (4): 451-456. https://doi.org/10.1016/j.eururo.2004.06.002
34.Sauvain J.L., Palascak P., Bourscheid D., Chabi C., Atassi A., Bremon J.M., Palascak R. Value of power doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer. Eur. Urol. 2003; 44 (1): 21-31. https://doi.org/10.1016/s0302-2838(03)00204-5
35.Zhu Y.C., Shan J., Zhang Y., Jiang Q., Wang Y.B., Deng S.H., Qu Q.H., Li Q. Prostate cancer vascularity: superb microvascular imaging ultrasonography with histopathology correlation. Med. Sci. Monit. 2019; 25: 8571-8578. https://doi.org/10.12659/msm.918318
36.Sidhu P.S., Cantisani V., Dietrich C.F., Gilja O.H., Saftoiu A., Bartels E., Bertolotto M., Calliada F., Clevert D.A., Cosgrove D., Deganello A., D’Onofrio M., Drudi F.M., Freeman S., Harvey C., Jenssen C., Jung E.M., Klauser A.S., Lassau N., Meloni M.F., Leen E., Nicolau C., Nolsoe C., Piscaglia F., Prada F., Prosch H., Radzina M., Savelli L., Weskott H.P., Wijkstra H. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall Med. 2018; 39 (2): e2-e44. https://doi.org/10.1055/a-0586-1107
37.Li Y., Tang J., Fei X., Gao Y. Diagnostic performance of contrast enhanced ultrasound in patients with prostate cancer: a meta-analysis. Acad. Radiol. 2013; 20 (2): 156-164. https://doi.org/10.1016/j.acra.2012.09.018
38.Roy C., Buy X., Lang H., Saussine C., Jacqmin D. Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral. zone tumors and role for biopsy procedure. J. Urol. 2003; 170 (1): 69-72. https://doi.org/10.1097/01. ju.0000072342.01573.8d
39.Mitterberger M.J., Aigner F., Horninger W., Ulmer H., Cavuto S., Halpern E.J., Frauscher F. Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection. Eur. Radiol. 2010; 20 (12): 2791-2796. https://doi.org/10.1007/s00330-010-1860-1
40.Halpern E.J., Gomella L.G., Forsberg F., McCue P.A., Trabulsi E.J. Contrast enhanced transrectal ultrasound for the detection of prostate cancer: a randomized, double-blind trial of dutasteride pretreatment. J. Urol. 2012; 188 (5): 17391745. https://doi.org/10.1016Zj.juro.2012.07.021
41.Trabulsi E.J., Calio B.P., Kamel S.I., Gomella L.G., Forsberg F., McCue P., Halpern E.J. Prostate contrast enhanced transrectal ultrasound evaluation of the prostate with whole-mount prostatectomy correlation. Urology. 2019; 133: 187-191. https://doi.org/10.1016/j.urology.2019.07.026
42.Sedelaar J.P., van Leenders G.J., Hulsbergen-van de Kaa C.A., van der Poel H.G., van der Laak J.A., Debruyne F.M., Wijkstra H., de la Rosette J.J. Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur. Urol. 2001; 40 (3): 285-293. https://doi.org/10.1159/000049788
43.Zhu Y., Chen Y., Jiang J., Wang R., Zhou Y., Zhang H. Contrast-enhanced harmonic ultrasonography for the assessment of prostate cancer aggressiveness: a preliminary study. Korean J. Radiol. 2010; 11 (1): 75-83. https://doi.org/10.3348/kjr. 2010.11.1.75
44.Sano F., Terao H., Kawahara T., Miyoshi Y., Sasaki T., Noguchi K., Kubota Y., Uemura H. Contrast-enhanced ultrasonography of the prostate: various imaging findings that indicate prostate cancer. BJUInt. 2011; 107 (9): 1404-1410. https://doi.org/10.1111/j.1464-410x.2010.09735.x
45.Yunkai Z., Yaqing C., Jun J., Tingyue Q., Weiyong L., Yuehong Q., Wenbin G., Lifeng W., Jun Q. Comparison of contrast-enhanced ultrasound targeted biopsy versus standard systematic biopsy for clinically significant prostate cancer detection: results of a prospective cohort study with 1024 patients. World J. Urol. 2019; 37 (5): 805-811. https://doi.org/10.1007/s00345-018-2441-1
46.Guo Y.F., Li F.H., Xie S.W., Xia J.G., Fang H., Li H.L. Value of contrast-enhanced sonographic micro flow imaging for prostate cancer detection with t-PSA level of 4-10 ng/mL. Eur. J. Radiol. 2012; 81 (11): 3067-3071. https://doi.org/10.1016/j.ejrad.2012.05.004
47.Dietrich C.F., Averkiou M.A., Correas J.M., Lassau N., Leen E., Piscaglia F. An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med. 2012; 33 (4): 344-351. https://doi.org/10.1055/s-0032-1313026
48.Кадрев А.В., Митькова М.Д., Рязанцев А.А., Камалов А.А., Митьков В.В. Количественный анализ трансректального ультразвукового исследования с контрастным усилением в диагностике рака предстательной железы (индексы): предварительные результаты. Ультразвуковая и функциональная диагностика. 2020; 3: 12-25. https://doi.org/10.24835/1607-0771-2020-3-12-25
49.Baur A.D.J., Schwabe J., Rogasch J., Maxeiner A., Penzkofer T., Stephan C., Rudl M., Hamm B., Jung E.M., Fischer T. A direct comparison of contrast-enhanced ultrasound and dynamic contrast- enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness. Eur. Radiol. 2018; 28 (5): 1949-1960. https://doi.org/10.1007/s00330-017-5192-2
50.Jiang J., Chen Y.Q., Zhu Y.K., Yao X.H., Qi J. Factors influencing the degree of enhancement of prostate cancer on contrast-enhanced transrectal ultrasonography: correlation with biopsy and radical prostatectomy specimens. Br. J. Radiol. 2012; 85 (1019): e979-e986. https://doi.org/10.1259/bjr/63794331
51.Кадрев А.В., Митькова М.Д., Рязанцев А.А., Камалов А.А., Митьков В.В. Количественный анализ трансректального ультразвукового исследования с контрастным усилением в диагностике рака предстательной железы (абсолютные параметры): предварительные результаты. Ультразвуковая и функциональная диагностика. 2020; 2: 13-26. https://doi.org/10.24835/1607- 0771-2020-2-13-26
52.Tang J., Yang J.C., Li Y., Li J., Shi H. Peripheral zone hypoechoic lesions of the prostate: evaluation with contrast-enhanced gray scale transrectal ultra-sonography. J. Ultrasound Med. 2007; 26 (12): 1671-1679. https://doi.org/10.7863/jum.2007.6. 12.1671
53.Maxeiner A., Fischer T., Schwabe J., Baur A.D.J., Stephan C., Peters R., Slowinski T., von Laffert M., Marticorena Garcia S.R., Hamm B., Jung E.M. Contrast-enhanced ultrasound (CEUS) and quantitative perfusion analysis in patients with suspicion for prostate cancer. Ultraschall Med. 2019; 40 (3): 340-348. https://doi.org/10.1055/a-0594-2093
54.Huang H., Zhu Z.Q., Zhou Z.G., Chen L.S., Zhao M., Zhang Y., Li H.B., Yin L.P. Contrast-enhanced transrectal ultrasound for prediction of prostate cancer aggressiveness: the role of normal peripheral. zone time-intensity curves. Sci. Rep. 2016; 6: 38643. https://doi.org/10.1038/srep38643
55.Кадрев А.В., Митькова М.Д., Камалов Д.М., Данилова Н.В., Сорокин Н.И., Камалов А.А., Митьков В.В. Диагностика и оценка морфологической значимости рака предстательной железы при использовании относительных параметров количественного анализа ультразвукового исследования с контрастным усилением: предварительные результаты. Ультразвуковая и функциональная диагностика. 2020; 4: 13-33. https://doi.org/10.24835/1607-0771-2020-4-13-33
56.Correas J.M., Halpern E.J., Barr R.G., Ghai S., Walz J., Bodard S., Dariane C., de la Rosette J. Advanced ultrasound in the diagnosis of prostate cancer. World J. Urol. 2021; 39 (3): 661-676. https://doi.org/10.1007/s00345-020-03193-0
57.Kuenen M.P., Saidov T.A., Wijkstra H., de la Rosette J.J., Mischi M. Spatiotemporal correlation of ultrasound contrast agent dilution curves for angiogenesis localization by dispersion imaging. IEEE Trans. Ultrason. Ferroelectr. Freq. Control. 2013; 60 (12): 2665-2669. https://doi.org/10.1109/tuffc.2013.2865
58.van Sloun R.J., Demi L., Postema A.W., de la Rosette J.J., Wijkstra H., Mischi M. Ultrasoundcontrast-agent dispersion and velocity imaging for prostate cancer localization. Med. Image Anal. 2017; 35: 610-619. https://doi.org/10.1016/j. media.2016.09.010
59.Postema A.W., Frinking P.J., Smeenge M., De Reijke T.M., De la Rosette J.J., Tranquart F., Wijkstra H. Dynamic contrast-enhanced ultra-sound parametric imaging for the detection of prostate cancer. BJU Int. 2016; 117 (4): 598-603. https://doi.org/10.1111/bju.13116
60.Morozov A., Kozlov V., Rivas J.G., Teoh J.Y., Bezrukov E., Amosov A., Barret E., Taratkin M., Salomon G., Herrmann T.R.W., Gozen A., Enikeev D.; collaboration between ESUT, ESUI and Urotechnology WP of the Young Academic Urologists. A systematic review and meta-analysis of Histoscanning™ in prostate cancer diagnostics. World J. Urol. 2021; 39 (10): 3733-3740. https://doi.org/10.1007/s00345-021-03684-8
61.Braeckman J., Autier P., Soviany C., Nir R., Nir D., Michielsen D., Treurnicht K., Jarmulowicz M., Bleiberg H., Govindaraju S., Emberton M. The accuracy of transrectal ultrasonography sup- plemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int. 2008; 102 (11): 1560-1565. https://doi.org/10.1111/j.1464-410x.2008.07878.x
62.Simmons L.A., Autier P., Zat’ura F., Braeckman J., Peltier A., Romic I., Stenzl A., Treurnicht K., Walker T., Nir D., Moore C.M., Emberton M. Detection, localisation and characterisation of pros- tate cancer by prostate HistoScanning(™). BJU Int. 2012; 110 (1): 28-35. https://doi.org/10.1111/j.1464-410x.2011.10734.x
63.Schiffmann J., Fischer J., Tennstedt P., Beyer B., Bohm K., Michl U., Graefen M., Salomon G. Comparison of prostate cancer volume measured by HistoScanning™ and final histopathological results. World J. Urol. 2014; 32 (4): 939-944. https://doi.org/10.1007/s00345-013-1211-3
64.Porres D., Kuru T.H., Epplen R., Eck A., Zugor V., Kennes L.N., Afram S., Braunschweig T., Knuchel-Clarke R., Pfister D., Heidenreich A. Sextant-specific analysis of detection and tumor volume by HistoScanning™. Urol. Int. 2016; 96 (2): 194-201. https://doi.org/10.1159/000440814.
65.Bigler S.A., Deering R.E., Brawer M.K. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum. Pathol. 1993; 24 (2): 220-226. https://doi.org/10.1016/0046-8177(93)90304-y.
66.Tuxhorn J.A., Ayala G.E., Smith M.J., Smith V.C., Dang T.D., Rowley D.R. Reactive stroma in human prostate cancer: induction of myofibroblast pheno-type and extracellular matrix remodeling. Clin. Cancer Res. 2002; 8 (9): 2912-2923.
67.Barr R.G., Cosgrove D., Brock M., Cantisani V., Correas J.M., Postema A.W., Salomon G., Tsutsumi M., Xu H.X., Dietrich C.F. WFUMB guidelines and recommendations on the clinical use of ultrasound elastography: part 5. Prostate. Ultrasound Med. Biol. 2017; 43 (1): 27-48. https://doi.org/10.1016/j.ultrasmedbio.2016.06.020.
68.Xu G., Feng L., Yao M., Wu J., Guo L., Yao X., Zhao L., Xu H., Wu R. A new 5-grading score in the diagnosis of prostate cancer with real-time elastography. Int. J. Clin. Exp. Pathol. 2014; 7 (7): 4128-4135.
69.Kamoi K., Okihara K., Ochiai A., Ukimura O., Mizutani Y., Kawauchi A., Miki T. The utility of transrectal real-time elastography in the diagnosis of prostate cancer. Ultrasound Med. Biol. 2008; 34 (7): 1025-1032. https://doi.org/10.1016/j.ultrasmedbio.2007.12.002.
70.Zhang Y., Tang J., Li Y.M., Fei X., Lv F.Q., He E.H., Li Q.Y., Shi H.Y. Differentiation of prostate cancer from benign lesions using strain index of transrectal real-time tissue elastography. Eur. J. Radiol. 2012; 81 (5): 857-862. https://doi.org/10.1016/j.ejrad.2011.02.037.
71.Schiffmann J., Grindei M., Tian Z., Yassin D.J., Steinwender T., Leyh-Bannurah S.R., Randazzo M., Kwiatkowski M., Karakiewicz P.I., Hammerer P., Manka L. Limitations of elastography based prostate biopsy. J. Urol. 2016; 195 (6): 1731-1736. https://doi.org/10.1016Zj.juro.2015.12.086.
72.Zhang B., Ma X., Zhan W., Zhu F., Li M., Huang J., Li Y., Xue L., Liu L., Wei Y. Real-time elastography in the diagnosis of patients suspected of having prostate cancer: a meta-analysis. Ultrasound Med. Biol. 2014; 40 (7): 1400-1407. https://doi.org/10.1016/j.ultrasmedbio.2014.02.020.
73.Brock M., von Bodman C., Palisaar R.J., Loppenberg B., Sommerer F., Deix T., Noldus J., Eggert T. The impact of real-time elastography guiding a systematic prostate biopsy to improve cancer detection rate: a prospective study of 353 patients. J. Urol. 2012; 187 (6): 2039-2043. https://doi.org/10.1016/j.juro.2012.01.063.
74.Pallwein L., Mitterberger M., Pinggera G., Aigner F., Pedross F., Gradl J., Pelzer A., Bartsch G., Frauscher F. Sonoelastography of the prostate: comparison with systematic biopsy findings in 492 patients. Eur. J. Radiol. 2008; 65 (2): 304-310. https://doi.org/10.1016/j.ejrad.2007.03.032.
75.Salomon G., Kollerman J., Thederan I., Chun F.K., Budaus L., Schlomm T., Isbarn H., Heinzer H., Huland H., Graefen M. Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. Eur. Urol. 2008; 54 (6): 1354-1362. https://doi.Org/10.1016/j. eururo.2008.02.035
76.Barr R.G., Memo R., Schaub C.R. Shear wave ultra-sound elastography of the prostate: initial results. Ultrasound Q. 2012; 28 (1): 13-20. https://doi.org/10.1097/ruq.0b013e318249f594
77.Митьков В.В., Васильева А.К., Митькова М.Д. Ультразвуковая эластография сдвиговой волны у больных с подозрением на рак предстательной железы. Ультразвуковая и функциональная диагностика. 2012; 5: 18-29.
78.Митьков В.В., Васильева А.К., Митькова М.Д. Механические (упругие) свойства предстательной железы при эластографии сдвиговой волны. Ультразвуковая и функциональная диагностика. 2012; 6:16-25.
79.Correas J.M., Tissier A.M., Khairoune A., Vassiliu V., Mejean A., Helenon O., Memo R., Barr R.G. Prostate cancer: diagnostic performance of real-time shear-wave elastography. Radiology. 2015; 275 (1): 280-289. https://doi.org/10.1148/radiol.14140567
80.Rouviere O., Melodelima C., Hoang Dinh A., Bratan F., Pagnoux G., Sanzalone T., Crouzet S., Colombel M., Mege-Lechevallier F., Souchon R. Stiffness of benign and malignant prostate tissue measured by shear-wave elastography: a preliminary study. Eur. Radiol. 2017; 27 (5): 1858-1866. https://doi.org/10.1007/s00330-016-4534-9
81.Глыбочко П.В., Аляев Ю.Г., Амосов А.В., Крупинов Г.Е., Ганжа Т.М., Воробьев А.В., Лумпов И.С., Семендяев Р.И. Диагностика рака предстательной железы с помощью оценки жесткости различных типов ткани с использованием ультразвуковой эластометрии сдвиговой волной. Урология. 2016; 3: 56-61.
82.Кадрев А.В., Митькова М.Д., Камалов Д.М., Данилова Н.В., Камалов А.А., Митьков В.В. Прицельная эластометрия (эластография сдвиговой волной) в диагностике рака предстательной железы (предварительные результаты). Ультразвуковая и функциональная диагностика. 2019; 1: 17-29. https://doi.org/10.24835/1607- 0771-2019-1-17-29
83.Ahmad S., Cao R., Varghese T., Bidaut L., Nabi G. Transrectal quantitative shear wave elastography in the detection and characterisation of prostate cancer. Surg. Endosc. 2013; 27 (9): 3280-3287. https://doi.org/10.1007/s00464-013-2906-7
84.Митьков В.В., Васильева А.К., Митькова М.Д. Диагностическая информативность ультразвуковой эластографии сдвиговой волной в диагностике рака предстательной железы. Ультразвуковая и функциональная диагностика. 2013; 5: 30-43.
85.Boehm K., Budaus L., Tennstedt P., Beyer B., Schiffmann J., Larcher A., Simonis K., Graefen M., Beyersdorff D., Salomon G. Prediction of significant prostate cancer at prostate biopsy and per core detection rate of targeted and systematic biopsies using real-time shear wave elastography. Urol. Int. 2015; 95 (2): 189-196. https://doi.org/10.1159/000431233
86.Woo S., Kim S.Y., Cho J.Y., Kim S.H. Shear wave elastography for detection of prostate cancer: a preliminary study. Korean J. Radiol. 2014;15(3): 346-355. https://doi.org/10.3348/kjr. 2014.15.3.346
87.Su R., Xu G., Xiang L., Ding S., Wu R. A novel scoring system for prediction of prostate cancer based on shear wave elastography and clinical parameters. Urology. 2018; 121: 112-117. https://doi.org/10.1016Zj.urology.2018.08.026
88.Ji Y., Ruan L., Ren W., Dun G., Liu J., Zhang Y., Wan Q. Stiffness of prostate gland measured by transrectal real-time shear wave elastography for detection of prostate cancer: a feasibility study. Br. J. Radiol. 2019; 92 (1097): 20180970. https://doi.org/10.1259/bjr.20180970
89.Амосов А.В., Крупинов Г.Е., Лернер Ю.В., Семендяев Р.И., Лумпов И.С., Митькова М.Д., Митьков В.В. Ультразвуковая эластография сдвиговой волной в диагностике рака предстательной железы (ретроспективное исследование). Ультразвуковая и функциональная диагностика.2016; 4: 10-17.
90.Wei C., Li C., Szewczyk-Bieda M., Upreti D., Lang S., Huang Z., Nabi G. Performance characteristics of transrectal shear wave elastography imaging in the evaluation of clinically localized prostate cancer: a prospective study. J. Urol. 2018; 200 (3): 549-558. https://doi.org/10.1016/j.juro.2018.03.116
91.Saftoiu A., Gilja O.H., Sidhu P.S., Dietrich C.F., Cantisani V., Amy D., Bachmann-Nielsen M., Bob F., Bojunga J., Brock M., Calliada F., Clevert D.A., Correas J.M., D’Onofrio M., Ewertsen C., Farrokh A., Fodor D., Fusaroli P., Havre R.F., Hocke M., Ignee A., Jenssen C., Klauser A.S., Kollmann C., Radzina M., Ramnarine K.V., Sconfienza L.M., Solomon C., Sporea I., Stefanescu H., Tanter M., Vilmann P. The EFSUMB guidelines and recommendations for the clinical practice of elastography in non-hepatic applications: update 2018. Ultraschall Med. 2019; 40 (4): 425-453. https://doi.org/10.1055/a-0838-9937
92.Boehm K., Salomon G., Beyer B., Schiffmann J., Simonis K., Graefen M., Budaeus L. Shear wave elastography for localization of prostate cancer lesions and assessment of elasticity thresholds: implications for targeted biopsies and active surveillance protocols. J. Urol. 2015; 193 (3): 794800. https://doi.org/10.1016/j.juro.2014.09.100
93.Камалов А.А., Кадрев А.В., Митькова М.Д., Данилова Н.В., Камалов Д.М., Сорокин Н.И., Митьков В.В. Использование прицельной биопсии под контролем эластографии сдвиговой волной в диагностике рака предстательной железы. Урология. 2020; 6: 106-113. https://dx.doi.org/10.18565/urology.2020.6.106-113
94.Кадрев А.В., Митькова М.Д., Камалов А.А., Митьков В.В. Эластография сдвиговой волной в оценке местного распространения рака предстательной железы. Ультразвуковая и функциональная диагностика. 2019; 1: 30-44. https://dx.doi.org/10.24835/1607-0771-2019-1-30-44
95.Anbarasan T., Wei C., Bamber J.C., Barr R.G., Nabi G. Characterisation of prostate lesions using transrectal shear wave elastography (SWE) ultra-sound imaging: a systematic review. Cancers (Basel). 2021; 13 (1): 122. https://dx.doi.org/10.3390/cancers13010122
96.Митьков В.В., Митькова М.Д., Салтыкова В.Г. Микроультразвуковое исследование - новые технологии, новые возможности. Ультразвуковая и функциональная диагностика. 2021; 1: 89-99. https://doi.org/10.24835/1607-0771-2021-1-89-99
97.Laurence Klotz C.M. Can high resolution micro-ultrasound replace MRI in the diagnosis of prostate cancer? Eur. Urol. Focus. 2020; 6 (2): 419-423. https://doi.org/10.1016/j.euf.2019.11.006
98.Hofbauer S.L., Luger F., Harland N., Plage H., Reimann M., Hollenbach M., Gusenleitner A., Stenzl A., Schlomm T., Wiemer L., Cash H. A non-inferiority comparative analysis of micro-ultra-sonography and MRI-targeted biopsy in men at risk of prostate cancer. BJU Int. 2021. https://doi.org/10.1111/bju.15635
99.Sountoulides P., Pyrgidis N., Polyzos S.A., Mykoniatis I., Asouhidou E., Papatsoris A., Dellis A., Anastasiadis A., Lusuardi L., Hatzichristou D. Micro-ultrasound-guided vs multiparametric magnetic resonance imaging-targeted biopsy in the detection of prostate cancer: a systematic review and meta-analysis. J. Urol. 2021; 205 (5): 1254-1262. https://doi.org/10.1097/ju.0000000000001639
100.Ghai S., Eure G., Fradet V., Hyndman M.E., McGrath T., Wodlinger B., Pavlovich C.P. Assessing cancer risk on novel 29 MHz micro-ultrasound images of the prostate: creation of the micro-ultrasound protocol for prostate risk identification. J. Urol. 2016; 196 (2): 562-569. https://doi.org/10.1016/j.juro.2015.12.093
101.Oberlin D.T., Casalino D.D., Miller F.H., Meeks J.J. Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer. Abdom. Radiol. (NY). 2017; 42 (4): 1255-1258. https://doi.org/10.1007/s00261-016-0975-5
102.Barentsz J.O., Richenberg J., Clements R., Choyke P., Verma S., Villeirs G., Rouviere O., Logager V., Futterer J.J.; European Society of Urogenital Radiology. ESUR prostate MR guidelines 2012. Eur. Radiol. 2012; 22 (4): 746-757. https://doi.org/10.1007/s00330-011-2377-y
103.Weinreb J.C., Barentsz J.O., Choyke P.L., Cornud F., Haider M.A., Macura K.J., Margolis D., Schnall M.D., Shtern F., Tempany C.M., Thoeny H.C., Verma S. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur. Urol. 2016; 69 (1): 16-40. https://doi.org/10.1016/j.eururo.2015.08.052
104.Turkbey B., Rosenkrantz A.B., Haider M.A., Padhani A.R., Villeirs G., Macura K.J., Tempany C.M., Choyke P.L., Cornud F., Margolis D.J., Thoeny H.C., Verma S., Barentsz J., Weinreb J.C. Prostate Imaging Reporting and Data System Version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2. Eur. Urol. 2019; 76 (3): 340-351. https://doi.org/10.1016/j.eururo.2019.02.033
105.Drost F.H., Osses D.F., Nieboer D., Steyerberg E.W., Bangma C.H., Roobol M.J., Schoots I.G. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. 2019; 4 (4): CD012663. https://doi.org/10.1002/14651858.cd012663.pub2
106.Wegelin O., Exterkate L., van der Leest M., Kummer J.A., Vreuls W., de Bruin P.C., Bosch J.L.H.R., Barentsz J.O., Somford D.M., van Melick H.H.E. The FUTURE trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies. Eur. Urol. 2019; 75 (4): 582-590. https://doi.org/10.1016/j.eururo.2018.11.040
107.Cool D.W., Zhang X., Romagnoli C., Izawa J.I., Romano W.M., Fenster A. Evaluation of MRI-TRUS fusion versus cognitive registration accuracy for MRI-targeted, TRUS-guided prostate biopsy. AJR Am. J. Roentgenol. 2015; 204 (1): 83-91. https://doi.org/10.2214/ajr.14.12681
108.Yamada Y., Shiraishi T., Ueno A., Ueda T., Fujihara A., Naitoh Y., Hongo F., Ukimura O. Magnetic resonance imaging-guided targeted prostate biopsy: comparison between computer-software-based fusion versus cognitive fusion technique in biopsy-naive patients. Int. J. Urol. 2020; 27 (1): 67-71. https://doi.org/10.1111/iju.14127
109.Das C.J., Razik A., Sharma S., Verma S. Prostate biopsy: when and how to perform. Clin. Radiol. 2019; 74 (11): 853-864. https://doi.org/10.1016/j.crad.2019.03.016
110.Baco E., Rud E., Eri L.M., Moen G., Vlatkovic L., Svindland A., Eggesbo H.B., Ukimura O. A randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy. Eur. Urol. 2016; 69 (1): 149-156. https://doi.org/10.1016/j.eururo.2015.03.041
111.Rouviere O., Puech P., Renard-Penna R., Claudon M., Roy C., Mege-Lechevallier F., Decaussin-Petrucci M., Dubreuil-Chambardel M., Magaud L., Remontet L., Ruffion A., Colombel M., Crouzet S., Schott A.M., Lemaitre L., Rabilloud M., Grenier N.; MRI-FIRST Investigators. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol. 2019; 20 (1): 100-109. https://doi.org/10.1016/s1470-2045(18)30569-2
112.Schoots I.G., Roobol M.J., Nieboer D., Bangma C.H., Steyerberg E.W., Hunink M.G. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultra-sound-guided biopsy: a systematic review and meta-analysis. Eur. Urol. 2015; 68 (3): 438-450. https://doi.org/10.1016/j.eururo.2014.11.037
113.Zhang M., Tang J., Luo Y., Wang Y., Wu M., Memmott B., Gao J. Diagnostic performance of multiparametric transrectal ultrasound in localized prostate cancer: a comparative study with magnetic resonance imaging. J. Ultrasound Med. 2019; 38 (7): 1823-1830. https://doi.org/10.1002/jum.14878
114.Maxeiner A., Stephan C., Durmus T., Slowinski T., Cash H., Fischer T. Added value of multiparametric ultrasonography in magnetic resonance imaging and ultrasonography fusion-guided biopsy of the prostate in patients with suspicion for prostate cancer. Urology. 2015; 86 (1): 108-114. https://doi.org/10.1016/j.urology.2015.01.055

Multiparametric ultrasound in prostate cancer diagnosis

The review presents transrectal ultrasound various modalities application in the diagnosis of prostate cancer. It provides the data on diagnostic value of B-mode ultrasound (including micro-ultrasound using ultra-high frequency), various technologies of blood flow evaluation (including micro-Doppler), HistoScanning, qualitative and quantitative elastography, and qualitative and quantitative contrastenhanced ultrasound. The role of magnetic resonance/transrectal ultrasound fusion in prostate biopsy is shown. The perspective for various modalities combining into a multiparametric transrectal ultrasound and possibility of development of standardized scales for ultrasound report are discussed. The available data confirms that the use of modern technologies increases accuracy of transrectal ultrasound in prostate cancer diagnosis, including detection of clinically significant prostate cancer.

Keywords:
трансректальное ультразвуковое исследование (ТРУЗИ), допплеровское исследование, ультразвуковое исследование с контрастным усилением, ультразвуковая эластография, микродопплеровское картирование, микроультразвуковое исследование, мультипараметрическое ультразвуковое исследование, магнитно-резонансное и ультразвуковое совмещение (фьюжен), рак предстательной железы, transrectal ultrasound (TRUS), Do